Recent Advancements in the Diagnosis, Prevention, and Prospective Drug Therapy of Covid-19

Bibliographic Data

ID22069636
AuthorsWaquar Ahsan (0000-0002-5987-2933, Jazan University, corresponding author), Hassan A Alhazmi (0000-0002-9647-9006, Jazan University), Kuldeep Singh Patel, Kuldeep Patel (0000-0003-4323-4264), Bharti Mangla (0000-0001-5125-2150, Jamia Hamdard), Mohammed Al Bratty (Jazan University), Shamama Javed (0000-0003-2145-9956, Jazan University), Asim Najmi (0000-0002-7529-5523, Jazan University), Muhammad H Sultan (0000-0002-1389-1899, Jazan University), Hafiz A Makeen (0000-0002-1078-2478, Jazan University), Asaad Khalid (Jazan University), Syam Mohan (0000-0003-2077-1278, Jazan University), Manal Mohamed Elhassan Taha (0000-0003-0166-8929, Jazan University), Shahnaz Sultana (0000-0001-8845-2578, Jazan University)
Year2020
Volume8
Pages384-384
Publication date2020-07-10
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2020.00384
PMID32754570
OpenAlexW3041917079
LanguageEN
References cited94

Severe acute respiratory syndrome coronavirus (CoV)-2 (SARS-CoV-2), previously called 2019 novel CoV, emerged from China in late December 2019. This virus causes CoV disease-19 (COVID-19), which has been proven a global pandemic leading to a major outbreak. As of June 19, 2020, the data from the World Health Organization (WHO) showed more than 8.7 million confirmed cases in over 200 countries/regions. The WHO has declared COVID-19 as the sixth public health emergency of international concern on January 30, 2020. CoVs cause illnesses that range in severity from the common cold to severe respiratory illnesses and death. Nevertheless, with technological advances and imperative lessons gained from prior outbreaks, humankind is better outfitted to deal with the latest emerging group of CoVs. Studies on the development of in vitro diagnostic tests, vaccines and drug re-purposing are being carried out in this field. Currently, no approved treatment is available for SARS-CoV-2 given the lack of evidence. The results from preliminary clinical trials have been mixed as far as improvement in the clinical condition and reduction in the duration of treatment are concerned. A number of new clinical trials are currently in progress to test the efficacy and safety of various approved drugs. This review focuses on recent advancements in the field of development of diagnostic tests, vaccines and treatment approaches for COVID-19

Clinical trial · Disease · Drug · Drug development · Intensive care medicine · Outbreak · Pandemic · Pathology · Public health · COVID-19 Clinical Research Studies · Medicine · SARS-CoV-2 and COVID-19 Research · SARS-CoV-2 detection and testing · Pharmacology · Virology

Tools

Open DOIOpen Access